A detailed history of Rockefeller Capital Management L.P. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 916,240 shares of BMY stock, worth $51.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
916,240
Previous 927,025 1.16%
Holding current value
$51.5 Million
Previous $38.5 Million 23.16%
% of portfolio
0.13%
Previous 0.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $427,733 - $558,123
-10,785 Reduced 1.16%
916,240 $47.4 Million
Q2 2024

Aug 12, 2024

BUY
$40.25 - $52.99 $3.63 Million - $4.77 Million
90,101 Added 10.77%
927,025 $38.5 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $11.8 Million - $13.3 Million
244,951 Added 41.38%
836,924 $45.4 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $9.63 Million - $11.5 Million
-198,652 Reduced 25.13%
591,973 $30.4 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $9.09 Million - $10.2 Million
-157,003 Reduced 16.57%
790,625 $45.9 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $2.31 Million - $2.57 Million
36,294 Added 3.98%
947,628 $60.6 Million
Q1 2023

May 17, 2023

BUY
$65.71 - $74.53 $12.3 Million - $14 Million
187,528 Added 25.91%
911,334 $63.2 Million
Q4 2022

Mar 06, 2023

SELL
$68.48 - $81.09 $1.73 Million - $2.05 Million
-25,228 Reduced 3.37%
723,806 $52.1 Million
Q3 2022

Nov 02, 2022

BUY
$0.13 - $76.84 $12,991 - $7.68 Million
99,931 Added 15.4%
749,034 $53.2 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $4.48 Million - $4.94 Million
-61,714 Reduced 8.68%
649,103 $50 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $1.03 Million - $1.24 Million
16,774 Added 2.42%
710,817 $51.9 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $10.7 Million - $12.5 Million
-199,316 Reduced 22.31%
694,043 $43.3 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $3.31 Million - $3.88 Million
56,007 Added 6.69%
893,359 $52.9 Million
Q2 2021

Aug 10, 2021

BUY
$61.91 - $67.42 $14.5 Million - $15.8 Million
234,152 Added 38.82%
837,352 $56 Million
Q1 2021

May 11, 2021

BUY
$59.34 - $66.74 $2.58 Million - $2.9 Million
43,468 Added 7.77%
603,200 $38.1 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $2.68 Million - $3.04 Million
46,468 Added 9.05%
559,732 $34.7 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $3.25 Million - $3.6 Million
56,597 Added 12.39%
513,264 $30.9 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $293,561 - $343,201
5,355 Added 1.19%
456,667 $26.9 Million
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $9.48 Million - $13.8 Million
204,413 Added 82.79%
451,312 $25.2 Million
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $2.9 Million - $3.79 Million
58,990 Added 31.39%
246,899 $15.9 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $3.77 Million - $4.47 Million
88,067 Added 88.21%
187,909 $9.53 Million
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $4.81 Million - $5.32 Million
-107,736 Reduced 51.9%
99,842 $4.53 Million
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $466,405 - $556,130
10,337 Added 5.24%
207,578 $9.9 Million
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $2.87 Million - $3.72 Million
58,786 Added 42.46%
197,241 $10.3 Million
Q3 2018

Nov 02, 2018

SELL
$55.19 - $62.25 $367,013 - $413,962
-6,650 Reduced 4.58%
138,455 $8.6 Million
Q2 2018

Jul 31, 2018

SELL
$50.53 - $62.98 $10.2 Million - $12.8 Million
-202,521 Reduced 58.26%
145,105 $8.03 Million
Q1 2018

May 09, 2018

BUY
$59.92 - $68.98 $20.8 Million - $24 Million
347,626 New
347,626 $22 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.